• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日间过度嗜睡作为帕金森病冲动控制障碍的一个风险因素。

Excessive Daytime Sleepiness as a Risk Factor for Impulse Control Disorders in Parkinson's Disease.

作者信息

Tang Xiaohui, Liang Qian, Li Tao, Ouyang Yetong, Huang Zhe Xue, Tang Xiaoshun, Jin Jiayi, Yu Lijia, Wang Xijin

机构信息

Department of Neurology, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.

Department of Neurology, Zhabei Central Hospital, Shanghai, People's Republic of China.

出版信息

Neuropsychiatr Dis Treat. 2024 Dec 13;20:2517-2527. doi: 10.2147/NDT.S485339. eCollection 2024.

DOI:10.2147/NDT.S485339
PMID:39691631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11651074/
Abstract

PURPOSE

Impulse control disorders (ICDs) and excessive daytime sleepiness (EDS) are common symptoms in Parkinson's disease (PD). Few longitudinal studies have focused on the association between EDS and ICDs. This longitudinal study aimed at assessing association between EDS and ICDs in PD.

PATIENTS AND METHODS

Patients without ICDs were incorporated from the Parkinson's Progression Markers Initiative. All patients were followed until the onset of ICDs or the end of 4 years. A total of 260 PD patients were included. Univariable and multivariable logistic regression were used to explore association between EDS and ICDs.

RESULTS

The overall frequency of ICDs at the end of follow-up was 23.8% (62 patients). The mean duration from dopamine replacement therapy to develop ICDs was 3.30 ± 2.42 years. Patients with ICDs had significantly higher Epworth Sleepiness Scale (ESS) score ( = 0.002) and higher proportion of EDS ( = 0.030) when compared to patients without ICDs. The multivariable logistic regression analysis indicated that high ESS (OR = 2.01, 95% CI 1.01-4.04, p = 0.049) score, high dopamine agonist equivalent daily dose (OR = 2.54, 95% CI 1.37-4.71, p = 0.003), high Geriatric Depression Scale (OR = 2.33, 95% CI 1.27-4.28, p = 0.006) score and postural instability (OR = 3.03, 95% CI 1.26-7.29, p = 0.013) were associated with ICDs occurrence.

CONCLUSION

Our results indicated that EDS acts as a risk for ICDs occurrence in PD. Clinicians should pay attention to EDS in clinical practice. This may be a promising new approach to better understand and therapy ICDs.

摘要

目的

冲动控制障碍(ICD)和日间过度嗜睡(EDS)是帕金森病(PD)的常见症状。很少有纵向研究关注EDS与ICD之间的关联。这项纵向研究旨在评估PD中EDS与ICD之间的关联。

患者与方法

从帕金森病进展标志物计划中纳入无ICD的患者。所有患者均随访至ICD发作或4年结束。共纳入260例PD患者。采用单变量和多变量逻辑回归来探讨EDS与ICD之间的关联。

结果

随访结束时ICD的总体发生率为23.8%(62例患者)。从多巴胺替代治疗到发生ICD的平均持续时间为3.30±2.42年。与无ICD的患者相比,有ICD的患者Epworth嗜睡量表(ESS)评分显著更高(P = 0.002),EDS比例更高(P = 0.030)。多变量逻辑回归分析表明,高ESS评分(OR = 2.01,95%CI 1.01 - 4.04,P = 0.049)、高多巴胺激动剂等效日剂量(OR = 2.54,95%CI 1.37 - 4.71,P = 0.003)、高老年抑郁量表评分(OR = 2.33,95%CI 1.27 - 4.28,P = 0.006)和姿势不稳(OR = 3.03,95%CI 1.26 - 7.29,P = 0.013)与ICD的发生相关。

结论

我们的结果表明,EDS是PD中发生ICD的一个风险因素。临床医生在临床实践中应关注EDS。这可能是更好地理解和治疗ICD的一种有前景的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccc/11651074/4e6b928634ab/NDT-20-2517-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccc/11651074/6c030128fe7f/NDT-20-2517-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccc/11651074/4e6b928634ab/NDT-20-2517-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccc/11651074/6c030128fe7f/NDT-20-2517-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccc/11651074/4e6b928634ab/NDT-20-2517-g0002.jpg

相似文献

1
Excessive Daytime Sleepiness as a Risk Factor for Impulse Control Disorders in Parkinson's Disease.日间过度嗜睡作为帕金森病冲动控制障碍的一个风险因素。
Neuropsychiatr Dis Treat. 2024 Dec 13;20:2517-2527. doi: 10.2147/NDT.S485339. eCollection 2024.
2
Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease.早期帕金森病日间过度嗜睡的纵向评估
J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):653-662. doi: 10.1136/jnnp-2016-315023. Epub 2017 May 29.
3
Clinical Features and Correlates of Excessive Daytime Sleepiness in Parkinson's Disease.帕金森病日间过度嗜睡的临床特征及相关因素
Front Neurol. 2019 Feb 19;10:121. doi: 10.3389/fneur.2019.00121. eCollection 2019.
4
Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease.帕金森病患者冲动控制障碍相关因素的 Meta 分析。
Neurosci Lett. 2019 Aug 10;707:134313. doi: 10.1016/j.neulet.2019.134313. Epub 2019 Jun 2.
5
A 3-year observation of excessive daytime sleepiness after subthalamic deep brain stimulation in patients with Parkinson's disease.帕金森病患者丘脑底核深部脑刺激术后日间过度嗜睡的3年观察
Clin Neurol Neurosurg. 2020 May;192:105721. doi: 10.1016/j.clineuro.2020.105721. Epub 2020 Feb 4.
6
Longitudinal Mediating Effect of Depression on the Relationship between Excessive Daytime Sleepiness and Activities of Daily Living in Parkinson's Disease.帕金森病患者日间过度嗜睡与日常生活活动能力的关系中抑郁的纵向中介作用。
Clin Gerontol. 2024 May-Jun;47(3):426-435. doi: 10.1080/07317115.2022.2111014. Epub 2022 Aug 11.
7
Excessive daytime sleepiness and its impact on quality of life in de novo Parkinson's disease.初诊帕金森病患者日间过度嗜睡及其对生活质量的影响。
Neurol Sci. 2019 Jun;40(6):1151-1156. doi: 10.1007/s10072-019-03785-8. Epub 2019 Feb 28.
8
Sleep quality, excessive daytime sleepiness, and depression in Parkinson's disease: implications for improved patient outcomes.帕金森病患者的睡眠质量、日间嗜睡和抑郁:对改善患者预后的影响。
Neurol Res. 2024 Apr;46(4):297-303. doi: 10.1080/01616412.2024.2301878. Epub 2024 Jan 24.
9
Factors contributing to sleep disturbances and excessive daytime sleepiness in patients with Parkinson's disease.帕金森病患者睡眠障碍和日间过度嗜睡的相关因素。
Front Neurol. 2023 Mar 9;14:1097251. doi: 10.3389/fneur.2023.1097251. eCollection 2023.
10
Prediction of Quality of Life in Patients With Parkinson's Disease With and Without Excessive Daytime Sleepiness: A Longitudinal Study.帕金森病伴或不伴日间过度嗜睡患者生活质量的预测:一项纵向研究。
Front Aging Neurosci. 2022 Apr 13;14:846563. doi: 10.3389/fnagi.2022.846563. eCollection 2022.

本文引用的文献

1
Prevalence and Influencing Factors of Depression in Patients with Parkinson's Disease.帕金森病患者抑郁的患病率及影响因素
Alpha Psychiatry. 2023 Nov 1;24(6):234-238. doi: 10.5152/alphapsychiatry.2023.231253. eCollection 2023 Nov.
2
Neuroimaging correlates of postural instability in Parkinson's disease.帕金森病患者姿势不稳的神经影像学相关性研究。
J Neurol. 2024 Apr;271(4):1910-1920. doi: 10.1007/s00415-023-12136-9. Epub 2023 Dec 18.
3
Epworth sleepiness scale: A meta-analytic study on the internal consistency.爱泼沃斯嗜睡量表:内部一致性的荟萃分析研究。
Sleep Med. 2023 Sep;109:261-269. doi: 10.1016/j.sleep.2023.07.008. Epub 2023 Jul 17.
4
Excessive daytime sleepiness in Parkinson's disease: the key is beyond sleep macrostructure.帕金森病中的日间过度嗜睡:关键在于睡眠宏观结构之外。
Sleep. 2023 Apr 12;46(4). doi: 10.1093/sleep/zsac209.
5
Excessive daytime sleepiness in a model of Parkinson's disease improved by low-frequency stimulation of the pedunculopontine nucleus.通过低频刺激脚桥核改善帕金森病模型中的日间过度嗜睡。
NPJ Parkinsons Dis. 2023 Jan 25;9(1):9. doi: 10.1038/s41531-023-00455-7.
6
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study.探索药物引起的冲动控制障碍的潜在机制:一项药物警戒-药效学研究。
Psychiatry Clin Neurosci. 2023 Mar;77(3):160-167. doi: 10.1111/pcn.13511. Epub 2022 Dec 21.
7
Understanding and approaching excessive daytime sleepiness.理解并应对日间过度嗜睡
Lancet. 2022 Sep 24;400(10357):1033-1046. doi: 10.1016/S0140-6736(22)01018-2. Epub 2022 Sep 14.
8
Genetic prediction of impulse control disorders in Parkinson's disease.帕金森病冲动控制障碍的遗传预测。
Ann Clin Transl Neurol. 2022 Jul;9(7):936-949. doi: 10.1002/acn3.51569. Epub 2022 Jun 27.
9
Dopamine-induced changes to thalamic GABA concentration in impulsive Parkinson disease patients.多巴胺对冲动型帕金森病患者丘脑γ-氨基丁酸浓度的影响
NPJ Parkinsons Dis. 2022 Apr 5;8(1):37. doi: 10.1038/s41531-022-00298-8.
10
Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee.多巴胺能疗法治疗早期帕金森病运动症状的实践指南摘要:AAN 指南小组委员会的报告。
Neurology. 2021 Nov 16;97(20):942-957. doi: 10.1212/WNL.0000000000012868.